Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
i&i Bio is a Luxembourg-based venture capital fund specializing in early-stage life science investments across the European Union, with a strong focus on the Central European region. Launched as a collaboration between i&i Prague and the European Investment Fund, the firm targets innovative technologies in drug discovery, medical devices, and diagnostics. i&i Bio leverages its close relationship with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) to identify and support high-potential academic spin-offs. The fund provides essential seed and Series A capital alongside strategic expertise to help bridge the gap between laboratory research and commercial application. Its investment strategy prioritizes breakthrough innovations with the potential to address significant unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on i&i Bio.